What is the current annual EBITDA of ISRG?

As of today, ISRG annual EBITDA is $3.61B

What is 1-year change in ISRG annual EBITDA?

ISRG annual EBITDA is up +28.64% year-over-year

What is 3-year change in ISRG annual EBITDA?

ISRG annual EBITDA is up +84.31% over the past 3 years

How far is ISRG annual EBITDA from its all-time high?

ISRG annual EBITDA is currently at its all-time high

How does ISRG annual EBITDA rank versus sector peers?

ISRG annual EBITDA is higher than 96.98% of companies in Healthcare sector

When is ISRG next annual earnings release?

The next annual earnings release for ISRG is on January 21, 2027

What is the current quarterly EBITDA of ISRG?

As of today, ISRG quarterly EBITDA is $1.24B

What is ISRG quarterly EBITDA most recent change?

ISRG quarterly EBITDA was up +4.33% on September 30, 2026

What is 1-year change in ISRG quarterly EBITDA?

ISRG quarterly EBITDA is up +34.79% year-over-year

How far is ISRG quarterly EBITDA from its all-time high?

ISRG quarterly EBITDA is currently at its all-time high

How does ISRG quarterly EBITDA rank versus sector peers?

ISRG quarterly EBITDA is higher than 96.90% of companies in Healthcare sector

When is ISRG next earnings release?

The next earnings release for ISRG is on January 21, 2027

What is the current TTM EBITDA of ISRG?

As of today, ISRG TTM EBITDA is $4.51B

What is ISRG TTM EBITDA most recent change?

ISRG TTM EBITDA was up +7.65% on September 30, 2026

What is 1-year change in ISRG TTM EBITDA?

ISRG TTM EBITDA is up +32.62% year-over-year

How far is ISRG TTM EBITDA from its all-time high?

ISRG TTM EBITDA is currently at its all-time high

How does ISRG TTM EBITDA rank versus sector peers?

ISRG TTM EBITDA is higher than 97.00% of companies in Healthcare sector

When is ISRG next earnings release?

The next earnings release for ISRG is on January 21, 2027

ISRG EBITDA History & Chart Since 1998

Annual EBITDA

$3.61B$803.30M+28.64%

December 31, 2025

Summary

Current Value: As of today, ISRG annual EBITDA is $3.61B, up +28.64% on December 31, 2025
Historical Performance: ISRG annual EBITDA is up +84.31% over the past 3 years, up +171.05% over the past 5 years
All-Time High Comparison: ISRG annual EBITDA is currently at its all-time high
3-Year Low Comparison: ISRG annual EBITDA is +84.31% above its 3-year low of $1.96B reached on an earlier date
Sector Comparison: ISRG annual EBITDA is higher than 96.98% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

ISRG Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$3.61B	+28.6%	+84.3%	+171.1%	+505.8%
Quarterly EBITDA	Sep 30, 26	$1.24B	+34.8%	+115.8%	+136.3%	+551.1%
TTM EBITDA	Sep 30, 26	$4.51B	+32.6%	+114.5%	+115.3%	+549.4%
Price	Nov 6, 26	$452.80	-17.3%	+63.3%	+24.1%	+842.8%
PE Ratio	Nov 6, 26	54.78	-24.4%	-16.1%	-30.5%	+46.6%
Annual Revenue	Dec 31, 25	$10.06B	+20.5%	+61.8%	+130.9%	+612.3%
Annual EPS	Dec 31, 25	$7.87	+22.7%	+115.6%	+167.9%	+648.4%
Annual EBIT	Dec 31, 25	$2.95B	+25.4%	+86.8%	+180.9%	+430.5%
Annual Net Income	Dec 31, 25	$2.88B	+23.1%	+114.0%	+169.7%	+653.4%

EBITDA Highs

ISRG Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$3.61B	Dec 31, 25	at high
5Y	$3.61B	Dec 31, 25	at high
All	$3.61B	Dec 31, 25	at high

EBITDA Lows

ISRG Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$1.96B	N/A	+84.3%
5Y	$1.33B	N/A	+171.1%
All	-$30.77M	Dec 31, 98	>+9999.0%

EBITDA History

Year	Value	Change
2025	$3.61B	+28.6%
2024	$2.80B	+27.4%
2023	$2.20B	+12.5%
2022	$1.96B	-8.4%
2021	$2.14B	+60.6%
2020	$1.33B	-15.5%
2019	$1.57B	+15.4%
2018	$1.36B	+15.3%
2017	$1.18B	+13.2%
2016	$1.05B	+25.7%
2015	$831.50M	+19.8%
2014	$694.10M	-24.4%
2013	$918.00M	-1.8%
2012	$934.80M	+26.0%

Year	Value	Change
2011	$742.00M	+24.6%
2010	$595.60M	+45.0%
2009	$410.87M	+22.3%
2008	$335.92M	+52.3%
2007	$220.59M	+88.0%
2006	$117.36M	+55.5%
2005	$75.50M	+168.2%
2004	$28.15M	+1,986.6%
2003	$1.35M	+108.3%
2002	-$16.33M	+5.4%
2001	-$17.27M	+14.1%
2000	-$20.10M	-11.0%
1999	-$18.11M	+41.1%
1998	-$30.77M	-

FAQ

What is the current annual EBITDA of ISRG?: As of today, ISRG annual EBITDA is $3.61B
What is 1-year change in ISRG annual EBITDA?: ISRG annual EBITDA is up +28.64% year-over-year
What is 3-year change in ISRG annual EBITDA?: ISRG annual EBITDA is up +84.31% over the past 3 years
How far is ISRG annual EBITDA from its all-time high?: ISRG annual EBITDA is currently at its all-time high
How does ISRG annual EBITDA rank versus sector peers?: ISRG annual EBITDA is higher than 96.98% of companies in Healthcare sector
When is ISRG next annual earnings release?: The next annual earnings release for ISRG is on January 21, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Quarterly EBITDA

$1.24B$51.50M+4.33%

September 30, 2026

Summary

Current Value: As of today, ISRG quarterly EBITDA is $1.24B, up +4.33% on September 30, 2026
Historical Performance: ISRG quarterly EBITDA is up +34.79% year-over-year, up +115.83% over the past 3 years
All-Time High Comparison: ISRG quarterly EBITDA is currently at its all-time high
3-Year Low Comparison: ISRG quarterly EBITDA is +119.73% above its 3-year low of $564.20M reached on December 31, 2023
Sector Comparison: ISRG quarterly EBITDA is higher than 96.90% of companies in Healthcare sector

Performance

ISRG Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$1.24B	+4.3%	+34.8%	+115.8%	+136.3%
Annual EBITDA	Dec 31, 25	$3.61B	–	+28.6%	+84.3%	+171.1%
TTM EBITDA	Sep 30, 26	$4.51B	+7.7%	+32.6%	+114.5%	+115.3%
Price	Nov 6, 26	$452.80	+21.2%	-17.3%	+63.3%	+24.1%
PE Ratio	Nov 6, 26	54.78	+27.9%	-24.4%	-16.1%	-30.5%
Quarterly Revenue	Sep 30, 26	$3.05B	+5.4%	+21.7%	+74.8%	+117.3%
Quarterly EPS	Sep 30, 26	$1.49	-35.1%	-23.6%	+28.1%	+43.3%
Quarterly EBIT	Sep 30, 26	$1.04B	+7.3%	+37.2%	+123.8%	+135.6%
Quarterly Net Income	Sep 30, 26	$524.40M	-36.3%	-26.1%	+24.9%	+35.4%

Quarterly EBITDA Highs

ISRG Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.24B	Sep 30, 26	at high
3Y	$1.24B	Sep 30, 26	at high
5Y	$1.24B	Sep 30, 26	at high
All	$1.24B	Sep 30, 26	at high

Quarterly EBITDA Lows

ISRG Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$919.70M	N/A	+34.8%
3Y	$564.20M	Dec 31, 23	+119.7%
5Y	$480.30M	Mar 31, 23	+158.1%
All	-$5.81M	Sep 30, 02	>+9999.0%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$1.24B	+4.3%
Jun 2026	$1.19B	+14.1%
Mar 2026	$1.04B	+0.5%
Dec 2025	$1.04B	+12.6%
Sep 2025	$919.70M	+2.3%
Jun 2025	$898.70M	+25.0%
Mar 2025	$719.00M	-16.4%
Dec 2024	$859.60M	+24.0%
Sep 2024	$693.50M	+2.1%
Jun 2024	$679.10M	+17.3%
Mar 2024	$578.70M	+2.6%
Dec 2023	$564.20M	-1.8%
Sep 2023	$574.40M	+2.5%
Jun 2023	$560.50M	+16.7%
Mar 2023	$480.30M	-0.9%
Dec 2022	$484.60M	-0.8%
Sep 2022	$488.70M	+1.1%
Jun 2022	$483.60M	-1.7%
Mar 2022	$491.90M	-7.8%
Dec 2021	$533.60M	+1.7%
Sep 2021	$524.70M	-11.1%
Jun 2021	$590.10M	+20.8%
Mar 2021	$488.50M	-0.2%
Dec 2020	$489.60M	+40.4%
Sep 2020	$348.70M	+140.8%
Jun 2020	$144.80M	-58.2%
Mar 2020	$346.50M	-24.4%
Dec 2019	$458.10M	+10.0%
Sep 2019	$416.60M	+2.7%
Jun 2019	$405.70M	+38.1%
Mar 2019	$293.80M	-20.1%
Dec 2018	$367.60M	+7.3%
Sep 2018	$342.50M	-1.9%
Jun 2018	$349.10M	+11.6%
Mar 2018	$312.70M	-13.8%
Dec 2017	$362.90M	+15.0%
Sep 2017	$315.50M	+7.8%
Jun 2017	$292.80M	+20.4%
Mar 2017	$243.10M	-15.8%
Dec 2016	$288.60M	+3.0%
Sep 2016	$280.10M	+1.0%
Jun 2016	$277.30M	+34.9%
Mar 2016	$205.60M	-22.2%
Dec 2015	$264.40M	+24.2%
Sep 2015	$212.90M	+5.7%
Jun 2015	$201.50M	+27.7%
Mar 2015	$157.80M	-25.5%
Dec 2014	$211.80M	+18.3%
Sep 2014	$179.00M	+5.4%
Jun 2014	$169.80M	+20.4%
Mar 2014	$141.00M	-37.8%
Dec 2013	$226.70M	+18.8%
Sep 2013	$190.80M	-18.8%
Jun 2013	$235.10M	-12.0%

Month	Value	Change
Mar 2013	$267.20M	+1.4%
Dec 2012	$263.50M	+9.6%
Sep 2012	$240.50M	+0.5%
Jun 2012	$239.20M	+15.8%
Mar 2012	$206.60M	-2.5%
Dec 2011	$212.00M	+11.3%
Sep 2011	$190.40M	+6.2%
Jun 2011	$179.30M	+12.3%
Mar 2011	$159.60M	-3.0%
Dec 2010	$164.50M	+15.5%
Sep 2010	$142.40M	-3.5%
Jun 2010	$147.60M	+6.0%
Mar 2010	$139.20M	+1.6%
Dec 2009	$137.06M	+20.8%
Sep 2009	$113.44M	+4.6%
Jun 2009	$108.49M	+104.6%
Mar 2009	$53.02M	-41.2%
Dec 2008	$90.24M	-1.7%
Sep 2008	$91.82M	+8.8%
Jun 2008	$84.36M	+21.4%
Mar 2008	$69.50M	-9.9%
Dec 2007	$77.18M	+34.3%
Sep 2007	$57.47M	+18.5%
Jun 2007	$48.49M	+29.5%
Mar 2007	$37.46M	-2.7%
Dec 2006	$38.49M	+36.1%
Sep 2006	$28.28M	+5.9%
Jun 2006	$26.70M	+11.7%
Mar 2006	$23.90M	-5.5%
Dec 2005	$25.30M	+11.7%
Sep 2005	$22.65M	+33.5%
Jun 2005	$16.97M	+60.4%
Mar 2005	$10.58M	-16.4%
Dec 2004	$12.65M	+75.5%
Sep 2004	$7.21M	+16.9%
Jun 2004	$6.17M	+190.3%
Mar 2004	$2.12M	+289.7%
Dec 2003	$545.00K	-47.4%
Sep 2003	$1.04M	-39.9%
Jun 2003	$1.72M	+183.8%
Mar 2003	-$2.06M	-5.9%
Dec 2002	-$1.94M	+66.6%
Sep 2002	-$5.81M	-76.9%
Jun 2002	-$3.29M	+38.0%
Mar 2002	-$5.30M	-27.2%
Dec 2001	-$4.17M	+16.7%
Sep 2001	-$5.00M	-19.7%
Jun 2001	-$4.18M	-6.3%
Mar 2001	-$3.93M	+25.7%
Dec 2000	-$5.29M	-5.4%
Sep 2000	-$5.02M	-4.3%
Jun 2000	-$4.81M	+3.5%
Mar 2000	-$4.98M	-

FAQ

What is the current quarterly EBITDA of ISRG?: As of today, ISRG quarterly EBITDA is $1.24B
What is ISRG quarterly EBITDA most recent change?: ISRG quarterly EBITDA was up +4.33% on September 30, 2026
What is 1-year change in ISRG quarterly EBITDA?: ISRG quarterly EBITDA is up +34.79% year-over-year
How far is ISRG quarterly EBITDA from its all-time high?: ISRG quarterly EBITDA is currently at its all-time high
How does ISRG quarterly EBITDA rank versus sector peers?: ISRG quarterly EBITDA is higher than 96.90% of companies in Healthcare sector
When is ISRG next earnings release?: The next earnings release for ISRG is on January 21, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

TTM EBITDA

$4.51B$320.00M+7.65%

September 30, 2026

Summary

Current Value: As of today, ISRG TTM EBITDA is $4.51B, up +7.65% on September 30, 2026
Historical Performance: ISRG TTM EBITDA is up +32.62% year-over-year, up +114.55% over the past 3 years
All-Time High Comparison: ISRG TTM EBITDA is currently at its all-time high
3-Year Low Comparison: ISRG TTM EBITDA is +114.55% above its 3-year low of $2.10B reached on an earlier date
Sector Comparison: ISRG TTM EBITDA is higher than 97.00% of companies in Healthcare sector

Performance

ISRG Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$4.51B	+7.7%	+32.6%	+114.5%	+115.3%
Annual EBITDA	Dec 31, 25	$3.61B	–	+28.6%	+84.3%	+171.1%
Quarterly EBITDA	Sep 30, 26	$1.24B	+4.3%	+34.8%	+115.8%	+136.3%
Price	Nov 6, 26	$452.80	+21.2%	-17.3%	+63.3%	+24.1%
PE Ratio	Nov 6, 26	54.78	+27.9%	-24.4%	-16.1%	-30.5%
TTM Revenue	Sep 30, 26	$11.58B	+4.9%	+20.4%	+69.0%	+111.0%
TTM EPS	Sep 30, 26	$8.27	-5.3%	+9.4%	+94.6%	+78.4%
TTM EBIT	Sep 30, 26	$3.73B	+8.2%	+32.6%	+121.1%	+109.0%
TTM Net Income	Sep 30, 26	$2.97B	-5.8%	+7.5%	+92.7%	+74.0%

TTM EBITDA Highs

ISRG TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$4.51B	Sep 30, 26	at high
3Y	$4.51B	Sep 30, 26	at high
5Y	$4.51B	Sep 30, 26	at high
All	$4.51B	Sep 30, 26	at high

TTM EBITDA Lows

ISRG TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$3.40B	N/A	+32.6%
3Y	$2.10B	N/A	+114.5%
5Y	$1.94B	Mar 31, 23	+132.6%
All	-$20.10M	Dec 31, 00	>+9999.0%

TTM EBITDA History

Month	Value	Change
Sep 2026	$4.51B	+7.6%
Jun 2026	$4.19B	+7.4%
Mar 2026	$3.90B	+9.0%
Dec 2025	$3.57B	+5.2%
Sep 2025	$3.40B	+7.1%
Jun 2025	$3.17B	+7.4%
Mar 2025	$2.95B	+5.0%
Dec 2024	$2.81B	+11.7%
Sep 2024	$2.52B	+5.0%
Jun 2024	$2.40B	+5.2%
Mar 2024	$2.28B	+4.5%
Dec 2023	$2.18B	+3.8%
Sep 2023	$2.10B	+4.3%
Jun 2023	$2.01B	+4.0%
Mar 2023	$1.94B	-0.6%
Dec 2022	$1.95B	-2.5%
Sep 2022	$2.00B	-1.8%
Jun 2022	$2.03B	-5.0%
Mar 2022	$2.14B	+0.2%
Dec 2021	$2.14B	+2.1%
Sep 2021	$2.09B	+9.2%
Jun 2021	$1.92B	+30.3%
Mar 2021	$1.47B	+10.7%
Dec 2020	$1.33B	+2.4%
Sep 2020	$1.30B	-5.0%
Jun 2020	$1.37B	-16.0%
Mar 2020	$1.63B	+3.3%
Dec 2019	$1.57B	+6.1%
Sep 2019	$1.48B	+5.3%
Jun 2019	$1.41B	+4.2%
Mar 2019	$1.35B	-1.4%
Dec 2018	$1.37B	+0.3%
Sep 2018	$1.37B	+2.0%
Jun 2018	$1.34B	+4.4%
Mar 2018	$1.28B	+5.7%
Dec 2017	$1.21B	+6.5%
Sep 2017	$1.14B	+3.2%
Jun 2017	$1.10B	+1.4%
Mar 2017	$1.09B	+3.6%
Dec 2016	$1.05B	+2.4%
Sep 2016	$1.03B	+7.0%
Jun 2016	$960.20M	+8.6%
Mar 2016	$884.40M	+5.7%
Dec 2015	$836.60M	+6.7%
Sep 2015	$784.00M	+4.5%
Jun 2015	$750.10M	+4.4%
Mar 2015	$718.40M	+2.4%
Dec 2014	$701.60M	-2.1%
Sep 2014	$716.50M	-1.6%
Jun 2014	$728.30M	-8.2%
Mar 2014	$793.60M	-13.7%
Dec 2013	$919.80M	-3.8%
Sep 2013	$956.60M	-4.9%
Jun 2013	$1.01B	-0.4%

Month	Value	Change
Mar 2013	$1.01B	+6.4%
Dec 2012	$949.80M	+5.7%
Sep 2012	$898.30M	+5.9%
Jun 2012	$848.20M	+7.6%
Mar 2012	$788.30M	+6.3%
Dec 2011	$741.30M	+6.8%
Sep 2011	$693.80M	+7.4%
Jun 2011	$645.80M	+5.2%
Mar 2011	$614.10M	+3.4%
Dec 2010	$593.70M	+4.8%
Sep 2010	$566.26M	+5.4%
Jun 2010	$537.30M	+7.9%
Mar 2010	$498.19M	+20.9%
Dec 2009	$412.02M	+12.8%
Sep 2009	$365.20M	+6.3%
Jun 2009	$343.57M	+7.6%
Mar 2009	$319.44M	-4.9%
Dec 2008	$335.92M	+4.0%
Sep 2008	$322.85M	+11.9%
Jun 2008	$288.50M	+14.2%
Mar 2008	$252.63M	+14.5%
Dec 2007	$220.59M	+21.3%
Sep 2007	$181.90M	+19.1%
Jun 2007	$152.72M	+16.6%
Mar 2007	$130.92M	+11.6%
Dec 2006	$117.36M	+12.7%
Sep 2006	$104.18M	+5.7%
Jun 2006	$98.55M	+11.0%
Mar 2006	$88.82M	+17.6%
Dec 2005	$75.50M	+20.1%
Sep 2005	$62.85M	+32.6%
Jun 2005	$47.41M	+29.5%
Mar 2005	$36.61M	+30.0%
Dec 2004	$28.15M	+75.5%
Sep 2004	$16.04M	+62.5%
Jun 2004	$9.87M	+81.9%
Mar 2004	$5.43M	+334.6%
Dec 2003	$1.25M	+201.1%
Sep 2003	-$1.24M	+84.7%
Jun 2003	-$8.08M	+38.3%
Mar 2003	-$13.09M	+19.9%
Dec 2002	-$16.33M	+12.0%
Sep 2002	-$18.56M	-4.6%
Jun 2002	-$17.75M	+4.8%
Mar 2002	-$18.64M	-7.9%
Dec 2001	-$17.27M	+6.1%
Sep 2001	-$18.39M	+0.1%
Jun 2001	-$18.41M	+3.3%
Mar 2001	-$19.04M	+5.2%
Dec 2000	-$20.10M	-35.7%
Sep 2000	-$14.81M	-51.2%
Jun 2000	-$9.79M	-96.5%
Mar 2000	-$4.98M	-

FAQ

What is the current TTM EBITDA of ISRG?: As of today, ISRG TTM EBITDA is $4.51B
What is ISRG TTM EBITDA most recent change?: ISRG TTM EBITDA was up +7.65% on September 30, 2026
What is 1-year change in ISRG TTM EBITDA?: ISRG TTM EBITDA is up +32.62% year-over-year
How far is ISRG TTM EBITDA from its all-time high?: ISRG TTM EBITDA is currently at its all-time high
How does ISRG TTM EBITDA rank versus sector peers?: ISRG TTM EBITDA is higher than 97.00% of companies in Healthcare sector
When is ISRG next earnings release?: The next earnings release for ISRG is on January 21, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Data Sources & References

ISRG Official Website www.intuitive.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1035267/000103526726000010/0001035267-26-000010-index.htm
ISRG Profile on Yahoo Finance finance.yahoo.com/quote/ISRG
ISRG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/isrg